Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
16 results:

  • 1. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
    Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
    Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]    [Full Text] [Related]  

  • 3. Bacterial infection promotes tumorigenesis of colorectal cancer via regulating CDC42 acetylation.
    Wang DN; Ni JJ; Li JH; Gao YQ; Ni FJ; Zhang ZZ; Fang JY; Lu J; Yao YF
    PLoS Pathog; 2023 Feb; 19(2):e1011189. PubMed ID: 36812247
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A genetic map of the chromatin regulators to drug response in cancer cells.
    Chen B; Li P; Liu M; Liu K; Zou M; Geng Y; Zhuang S; Xu H; Wang L; Chen T; Li Y; Zhao Z; Qi L; Gu Y
    J Transl Med; 2022 Sep; 20(1):438. PubMed ID: 36180906
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
    Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
    Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nanog mediated by FAO/ACLY signaling induces cellular dormancy in colorectal cancer cells.
    Zhang M; Peng R; Wang H; Yang Z; Zhang H; Zhang Y; Wang M; Wang H; Lin J; Zhao Q; Liu J
    Cell Death Dis; 2022 Feb; 13(2):159. PubMed ID: 35177584
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TRIB3 reduces CD8
    Shang S; Yang YW; Chen F; Yu L; Shen SH; Li K; Cui B; Lv XX; Zhang C; Yang C; Liu J; Yu JJ; Zhang XW; Li PP; Zhu ST; Zhang HZ; Hua F
    Sci Transl Med; 2022 Jan; 14(626):eabf0992. PubMed ID: 34985967
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
    Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
    Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
    [No Abstract]    [Full Text] [Related]  

  • 9. Characterization of genomic alterations in Chinese colorectal cancer patients.
    Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
    Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Acetylation of PHF5A Modulates Stress Responses and colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
    Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
    Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Wang YQ; Jiang DM; Hu SS; Zhao L; Wang L; Yang MH; Ai ML; Jiang HJ; Han Y; Ding YQ; Wang S
    Cancer Res; 2019 Jul; 79(14):3542-3556. PubMed ID: 30858153
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Histone demethylase KDM3A is required for enhancer activation of hippo target genes in colorectal cancer.
    Wang HY; Long QY; Tang SB; Xiao Q; Gao C; Zhao QY; Li QL; Ye M; Zhang L; Li LY; Wu M
    Nucleic Acids Res; 2019 Mar; 47(5):2349-2364. PubMed ID: 30649550
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer.
    Du C; Huang D; Peng Y; Yao Y; Zhao Y; Yang Y; Wang H; Cao L; Zhu WG; Gu J
    Cancer Lett; 2017 Aug; 400():183-193. PubMed ID: 28465257
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! online.
    Gill S; Loprinzi C; Kennecke H; Grothey A; Nelson G; Woods R; Speers C; Alberts SR; Bardia A; O'Connell MJ; Sargent DJ
    Cancer; 2011 Sep; 117(18):4155-65. PubMed ID: 21365628
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
    Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
    J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.